相似文献
1
Exploring the immunome: A brave new world for human vaccine development.
Hum Vaccin. 2009 Dec;5(12):790-3. doi: 10.4161/hv.10683. Epub 2009 Dec 15.
2
Predicting vaccine responsiveness.
Cell Host Microbe. 2015 Mar 11;17(3):301-307. doi: 10.1016/j.chom.2015.02.015.
3
Next Generation Vaccines for Infectious Diseases.
J Immunol Res. 2019 Apr 30;2019:5890962. doi: 10.1155/2019/5890962. eCollection 2019.
4
Reverse vaccinology: developing vaccines in the era of genomics.
Immunity. 2010 Oct 29;33(4):530-41. doi: 10.1016/j.immuni.2010.09.017.
5
New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.
J Immunol Res. 2017;2017:3104719. doi: 10.1155/2017/3104719. Epub 2017 Jul 5.
6
Cell-mediated immunity needed for TB vaccine.
Indian J Med Sci. 1998 Nov;52(11):521-2.
7
Vaccine adjuvants: current challenges and future approaches.
J Pharm Sci. 2009 Apr;98(4):1278-316. doi: 10.1002/jps.21523.
8
Prime-boost immunization strategies for infectious diseases.
Curr Opin Mol Ther. 2002 Feb;4(1):23-7.
9
Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design.
Pathog Glob Health. 2018 May;112(3):123-131. doi: 10.1080/20477724.2018.1446773. Epub 2018 Mar 12.
10
Methods for assessing cell-mediated immunity in infectious disease resistance and in the development of vaccines.
J Am Vet Med Assoc. 1995 Apr 15;206(8):1208-16.
引用本文的文献
1
Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
Arch Virol. 2020 Apr;165(4):891-911. doi: 10.1007/s00705-020-04537-2. Epub 2020 Feb 14.
2
Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.
Hum Vaccin Immunother. 2020 Apr 2;16(4):919-930. doi: 10.1080/21645515.2019.1678998. Epub 2019 Nov 11.
3
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
PLoS Pathog. 2014 Mar 27;10(3):e1004033. doi: 10.1371/journal.ppat.1004033. eCollection 2014 Mar.
本文引用的文献
1
Epitope-based vaccination against pneumonic tularemia.
Vaccine. 2009 Aug 27;27(39):5299-306. doi: 10.1016/j.vaccine.2009.06.101. Epub 2009 Jul 17.
2
Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics.
Clin Immunol. 2009 May;131(2):189-201. doi: 10.1016/j.clim.2009.01.009. Epub 2009 Mar 6.
3
Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".
Blood. 2008 Oct 15;112(8):3303-11. doi: 10.1182/blood-2008-02-138073. Epub 2008 Jul 25.
4
The measles campaign in West and Central Africa: remembering the future.
Vaccine. 2008 Jul 23;26(31):3783-6. doi: 10.1016/j.vaccine.2008.04.088. Epub 2008 Jun 2.
5
Novel function of complement C3d as an autologous helper T-cell target.
Immunol Cell Biol. 2008 Mar-Apr;86(3):221-5. doi: 10.1038/sj.icb.7100147. Epub 2008 Jan 8.
6
Evolutionary deimmunization: an ancillary mechanism for self-tolerance?
Cell Immunol. 2006 Dec;244(2):148-53. doi: 10.1016/j.cellimm.2007.02.006. Epub 2007 Apr 18.
7
New tools, new approaches and new ideas for vaccine development.
Expert Rev Vaccines. 2007 Apr;6(2):125-7. doi: 10.1586/14760584.6.2.125.
8
Private specificities of CD8 T cell responses control patterns of heterologous immunity.
J Exp Med. 2005 Feb 21;201(4):523-33. doi: 10.1084/jem.20041337. Epub 2005 Feb 14.
9
Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes.
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):95-105. doi: 10.1016/j.tube.2004.09.005. Epub 2004 Dec 25.
10
From genome to vaccine--new immunoinformatics tools for vaccine design.
Methods. 2004 Dec;34(4):425-8. doi: 10.1016/j.ymeth.2004.06.004.
Zotero 插件